Hypothalamic Obesity clinical trials

Explore recruiting hypothalamic obesity clinical trials.

Recruiting hypothalamic obesity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hypothalamic Obesity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PNOC029_Tovorafenib for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults

Netherlands, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

SEMAFORCRANIO : Multicenter, double-blind, parallel, randomized controlled trial of the efficacy of semaglutide in hypothalamic obesity secondary to craniopharyngioma in children aged 12 to 17 years

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hypothalamic Obesity trials by city

Hypothalamic Obesity in Toronto Hypothalamic Obesity in Vancouver Hypothalamic Obesity in Montreal Hypothalamic Obesity in Calgary Hypothalamic Obesity in Edmonton Hypothalamic Obesity in Ottawa Hypothalamic Obesity in Winnipeg Hypothalamic Obesity in Quebec City Hypothalamic Obesity in Hamilton Hypothalamic Obesity in Kitchener Hypothalamic Obesity in London Hypothalamic Obesity in Halifax Hypothalamic Obesity in New York Hypothalamic Obesity in Los Angeles Hypothalamic Obesity in Chicago Hypothalamic Obesity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease